Logo image of COUR.PA

COURTOIS-R (COUR.PA) Stock Fundamental Analysis

EPA:COUR - Euronext Paris - Matif - FR0000065393 - Common Stock - Currency: EUR

123  +7 (+6.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to COUR. COUR was compared to 10 industry peers in the Real Estate Management & Development industry. While COUR seems to be doing ok healthwise, there are quite some concerns on its profitability. COUR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year COUR has reported negative net income.
In the past year COUR has reported a negative cash flow from operations.
In multiple years COUR reported negative net income over the last 5 years.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR.PA Yearly Net Income VS EBIT VS OCF VS FCFCOUR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

COUR has a Return On Assets (-1.38%) which is comparable to the rest of the industry.
COUR has a Return On Equity of -1.89%. This is comparable to the rest of the industry: COUR outperforms 48.48% of its industry peers.
Industry RankSector Rank
ROA -1.38%
ROE -1.89%
ROIC N/A
ROA(3y)0.22%
ROA(5y)0.22%
ROE(3y)0.24%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
COUR.PA Yearly ROA, ROE, ROICCOUR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

COUR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COUR.PA Yearly Profit, Operating, Gross MarginsCOUR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COUR remains at a similar level compared to 1 year ago.
COUR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, COUR has a worse debt to assets ratio.
COUR.PA Yearly Shares OutstandingCOUR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K
COUR.PA Yearly Total Debt VS Total AssetsCOUR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

COUR has an Altman-Z score of 2.19. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR's Altman-Z score of 2.19 is amongst the best of the industry. COUR outperforms 87.88% of its industry peers.
COUR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, COUR belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 2.19
ROIC/WACCN/A
WACC6.31%
COUR.PA Yearly LT Debt VS Equity VS FCFCOUR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.37 indicates that COUR has no problem at all paying its short term obligations.
COUR has a better Current ratio (5.37) than 89.39% of its industry peers.
COUR has a Quick Ratio of 2.54. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
COUR has a Quick ratio of 2.54. This is amongst the best in the industry. COUR outperforms 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 2.54
COUR.PA Yearly Current Assets VS Current LiabilitesCOUR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

COUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -108.92%.
The Revenue for COUR has decreased by -32.93% in the past year. This is quite bad
COUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.36% yearly.
EPS 1Y (TTM)-108.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.73%
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y-38.77%
Revenue growth 5Y-30.36%
Sales Q2Q%-52.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COUR.PA Yearly Revenue VS EstimatesCOUR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COUR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COUR.PA Price Earnings VS Forward Price EarningsCOUR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COUR.PA Per share dataCOUR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

COUR has a Yearly Dividend Yield of 2.02%.
Compared to an average industry Dividend Yield of 3.79, COUR has a dividend in line with its industry peers.
COUR's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
COUR.PA Yearly Dividends per shareCOUR.PA Yearly Dividends per shareYearly Dividends per share 2019 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
COUR.PA Yearly Income VS Free CF VS DividendCOUR.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

COURTOIS-R

EPA:COUR (6/9/2025, 7:00:00 PM)

123

+7 (+6.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners80.73%
Ins Owner ChangeN/A
Market Cap8.61M
Analysts78.82
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.11
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-4.85
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-15.2
FCFYN/A
OCF(TTM)-11.4
OCFYN/A
SpS13.5
BVpS265.41
TBVpS265.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.38%
ROE -1.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.22%
ROA(5y)0.22%
ROE(3y)0.24%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 665%
Cap/Sales 28.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.37
Quick Ratio 2.54
Altman-Z 2.19
F-Score1
WACC6.31%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y-38.77%
Revenue growth 5Y-30.36%
Sales Q2Q%-52.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-122.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.6%
OCF growth 3YN/A
OCF growth 5YN/A